Rapid Improvement Seven Years After Stroke, February 2017

Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment for these indications is innovative (“off-label”). Please see the Terms of Use. The method of off-label treatment utilized is a patented invention of TransBarrier®. Copyright 2017 TransBarrier®, all rights reserved.